The role of Agatston score in stage III non small cell lung cancer patients
PD-0666
Abstract
The role of Agatston score in stage III non small cell lung cancer patients
Authors: Antonio Angrisani1, Giuseppina De Marco1, Valerio Nardone1, Emma D'Ippolito1, Roberta Grassi1, Alfonso Reginelli2, Cesare Guida3, Salvatore Cappabianca1
1"L. Vanvitelli" University of Campania, Precision Medicine - Radiotherapy Unit, Naples, Italy; 2"L. Vanvitelli" University of Campania, Precision Medicine - Radiology Unit, Naples, Italy; 3Ospedale del Mare, Radiotherapy, Naples, Italy
Show Affiliations
Hide Affiliations
Purpose or Objective
Radiation-induced cardiac toxicity and
radiation-related coronary artery disease (CAD) represent an important issue in
thoracic radiotherapy, although no reliable surrogate biomarkers are identified. The quantification of coronary calcium based on the
area of a calcified coronary plaque in a CT slice is called Agatston score, or
Coronary Artery Calcification Score (CAC Score) and could represent a potential
biomarker for radiation-induced cardiac toxicity. The aim of our work is to evaluate the prevalence and
severity of cardiac calcifications in third-stage lung cancer patients before
radical chemo-radiotherapy treatment.
Material and Methods
Between January 2018 and May 2021, patients with Stage
III non-small cell lung cancer (NSCLC) with a pre-treatment CT imaging of the
thorax that was discussed in the Multidisciplinary Tumor Board (MTB) of
thoracic malignancies in our Department were included. The clinical data of the patients were retrospectively
collected (sex, age, smoke exposure, stage) and the Agatston score was calculated
on CT imaging and was correlated with the clinical parameters (Chi-Square
analysis) and with overall survival (OS, with Kaplan-Meier analysis).
Results
A total of 84 patients were included in the present
analysis, , with a median OS of 30 months (mean 34,2 months, 95% CI 28-40
months). The four CAD Score subgroups differed in terms of sex
(p:0,010), age (p<0,001) and smoke exposure (p:0,001). The parameters that
resulted significantly correlated with a lower OS were the Stage (p<0,001)
and the CAD Grading (p:0,001).
Conclusion
The
prevalence of severe CAC Grading is exceedingly high in locally advanced lung
cancer patients that are amenable to undergoing different treatments. This subset
of patients, independently from the choice of treatment, should be referred to
the Cardiologist for prevention and strict follow-up of CAD.